Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NONPEPTIDE ANTAGONISTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Henlin, JM; Boutin, JA; Duchene-Roger, F; Nicolas, JP; Desmet-Beaufort, C; Levens, N; Fauchere, JL
      Parallel synthesis and pharmacological screening oi nonpeptide ligands of the neuropeptide Y receptor subtype Y-5

      JOURNAL OF PEPTIDE RESEARCH
    2. Ali, MA; Bhogal, N; Fishwick, CWG; Findlay, JBC
      Spatial requirements of the antagonist binding site of the NK2 receptor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Petit, T; Davidson, KK; Lawrence, RA; von Hoff, DD; Izbicka, E
      Neuropeptide receptor status in human tumor cell lines

      ANTI-CANCER DRUGS
    4. Souaze, F
      Maintaining cell sensitivity to G-protein coupled receptor agonists: Neurotensin and the role of receptor gene activation

      JOURNAL OF NEUROENDOCRINOLOGY
    5. Gurrath, M
      Peptide-binding G protein-coupled receptors: New opportunities for drug design

      CURRENT MEDICINAL CHEMISTRY
    6. Thibonnier, M; Coles, P; Thibonnier, A; Shoham, M
      The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    7. Peterlin-Masic, L; Kikelj, D
      Arginine mimetics

      TETRAHEDRON
    8. Blaney, FE; Raveglia, LF; Artico, M; Cavagnera, S; Dartois, C; Farina, C; Grugni, M; Gagliardi, S; Luttmann, MA; Martinelli, M; Nadler, GMMG; Parini, C; Petrillo, P; Sarau, HM; Scheideler, MA; Hay, DWP; Giardina, GAM
      Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    9. Labrou, NE; Bhogal, N; Hurrell, CR; Findlay, JBC
      Interaction of Met(297) in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Sarau, HM; Feild, JA; Ames, RS; Foley, JJ; Nuthulaganti, P; Schmidt, DB; Buckley, PT; Elshourbagy, NA; Brawner, ME; Luttmann, MA; Giardina, GAM; Hay, DWP
      Molecular and pharmacological characterization of the murine tachykinin NK3 receptor

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. Camara, AKS; Osborn, J
      Central AT(1) and AT(2) receptors mediate chronic intracerebroventricular angiotensin II-induced drinking in rats fed high sodium chloride diet from weaning

      ACTA PHYSIOLOGICA SCANDINAVICA
    12. Peyman, A; Gourvest, JF; Gadek, TR; Knolle, J
      Vitronectin receptor antagonists: Purine-based peptidomimetics

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    13. Leroy, V; Mauser, P; Gao, ZL; Peet, NP
      Neurokinin receptor antagonists

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    14. Giardina, GA; Grugni, M; Raveglia, LF
      Recent advances in neurokinin-3 receptor antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    15. Robertson, MJ
      Angiotensin antagonists (Reprinted from Receptor-Based Drug Design, pg 207-230, 1998)

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    16. Peyman, A; Wehner, V; Knolle, J; Stilz, HU; Breipohl, G; Scheunemann, KH; Carniato, D; Ruxer, JM; Gourvest, JF; Gadek, TR; Bodary, S
      RGD mimetics containing a central hydantoin scaffold: alpha(v)beta(3) vs alpha(IIb)beta(3) selectivity requirements

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    17. Vannucchi, MG; Faussone-Pellegrini, MS
      NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse

      ANATOMY AND EMBRYOLOGY
    18. Massi, M; Panocka, I; de Caro, G
      The psychopharmacology of tachykinin NK-3 receptors in laboratory animals

      PEPTIDES
    19. Gether, U
      Uncovering molecular mechanisms involved in activation of G protein-coupled receptors

      ENDOCRINE REVIEWS
    20. Patchett, AA; Nargund, RP
      Privileged structures - An update

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    21. Liu, J; Underwood, DJ; Cascieri, MA; Rohrer, SP; Cantin, LD; Chicchi, G; Smith, AB; Hirschmann, R
      Synthesis of a substance P antagonist with a somatostatin scaffold: Factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry

      JOURNAL OF MEDICINAL CHEMISTRY
    22. Mazzone, SB; Geraghty, DP
      Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    23. Miller, MD; Fluder, EM; Castonguay, LA; Culberson, JC; Mosley, RT; Prendergast, K; Kearsley, SK; Sheridan, RP
      MEGA-SQ: A method using the SQuEAL function to find the optimal superposition of several quasi-flexible molecules

      MEDICINAL CHEMISTRY RESEARCH
    24. Mayinger, B; Hensen, J
      Nonpeptide vasopressin antagonists: A new group of hormone blockers entering the scene

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    25. Pruneau, D; Chorny, I; Benkovitz, V; Artru, A; Roitblat, L; Shapira, Y
      Effect of LF 16-0687MS, a new nonpeptide bradykinin B-2 receptor antagonist, in a rat model of closed head trauma

      JOURNAL OF NEUROTRAUMA
    26. Schmidt, PT; Rickelt, LF; Holst, JJ
      Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors

      DIGESTIVE DISEASES AND SCIENCES
    27. Mann, JFE
      Valsartan and the kidney: Present and future

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    28. Rosenkilde, MM; Kledal, TN; Brauner-Osborne, H; Schwartz, TW
      Agonists and inverse agonists for the herpesvirus 8-encoded constitutivelyactive seven-transmembrane oncogene product, ORF-74

      JOURNAL OF BIOLOGICAL CHEMISTRY
    29. CHRISTOS TE; ARVANITIS A
      CORTICOTROPIN-RELEASING FACTOR-RECEPTOR ANTAGONISTS

      Expert opinion on therapeutic patents
    30. SOLDNER A; SPAHNLANGGUTH H; MUTSCHLER E
      HPLC ASSAYS TO SIMULTANEOUSLY DETERMINE THE ANGIOTENSIN-AT(1) ANTAGONIST LOSARTAN AS WELL AS ITS MAIN AND ACTIVE METABOLITE EXP3174 IN BIOLOGICAL-MATERIAL OF HUMANS AND RATS

      Journal of pharmaceutical and biomedical analysis
    31. HAN NL; SIM MK
      HYPOTHALAMIC ANGIOTENSIN RECEPTOR SUBTYPES IN NORMOTENSIVE AND HYPERTENSIVE RATS

      American journal of physiology. Heart and circulatory physiology
    32. HOLST B; ZOFFMANN S; ELLING CE; HJORTH SA; SCHWARTZ TW
      STERIC HINDRANCE MUTAGENESIS VERSUS ALANINE SCAN IN MAPPING OF LIGAND-BINDING SITES IN THE TACHYKININ NK1 RECEPTOR

      Molecular pharmacology
    33. DASCAL D; NIRULA V; LAWUS K; YOO SE; WALSH TF; SANDBERG K
      SHARED DETERMINANTS OF RECEPTOR-BINDING FOR SUBTYPE-SELECTIVE, AND DUAL ENDOTHELIN-ANGIOTENSIN ANTAGONISTS ON THE AT(1) ANGIOTENSIN-II RECEPTOR

      FEBS letters
    34. WIELAND HA; ECKARD CP; DOODS HN; BECKSICKINGER AG
      PROBING OF THE NEUROPEPTIDE Y-Y-1-RECEPTORS INTERACTION WITH ANTIRECEPTOR ANTIBODIES

      European journal of biochemistry
    35. LASIKOVA A; VEGH D; SMAHOVSKY V
      NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGO NISTS - POTENTIAL-DRUGS AGAINST HYPERTENSION

      Chemicke listy
    36. JACOBY E; BOUDON A; KUCHARCZYK N; MICHEL A; FAUCHERE JL
      A STRUCTURAL RATIONALE FOR THE DESIGN OF WATER-SOLUBLE PEPTIDE-DERIVED NEUROKININ-1 ANTAGONISTS

      Journal of receptor and signal transduction research
    37. NOZAWA Y; HARUNO A; ODA N; YAMASAKI Y; MATSUURA N; MIYAKE H; YAMADA S; KIMURA R
      PHARMACOLOGICAL PROFILE OF TH-142177, NOVEL ORALLY-ACTIVE AT(1)-RECEPTOR ANTAGONIST

      Fundamental and clinical pharmacology
    38. HEAVEY ML; LAU WAK; PENNEFATHER JN
      TACHYKININ RECEPTORS MEDIATING NONCHOLINERGIC CONTRACTION OF THE GUINEA-PIG ISOLATED MAIN BRONCHUS IN RESPONSE TO FIELD STIMULATION

      Clinical and experimental pharmacology and physiology
    39. SCHMIDT PT; RASMUSSEN TN; HOLST JJ
      TACHYKININS MAY MEDIATE CAPSAICIN-INDUCED, BUT NOT VAGALLY INDUCED MOTILITY IN PORCINE ANTRUM

      Peptides
    40. QUARTARA L; MAGGI CA
      THE TACHYKININ NK1 RECEPTOR - PART I - LIGANDS AND MECHANISMS OF CELLULAR ACTIVATION

      Neuropeptides
    41. BALMFORTH AJ; LEE AJ; WARBURTON P; DONNELLY D; BALL SG
      THE CONFORMATIONAL CHANGE RESPONSIBLE FOR AT(1) RECEPTOR ACTIVATION IS DEPENDENT UPON 2 JUXTAPOSED ASPARAGINE RESIDUES ON TRANSMEMBRANE-HELICES-III AND TRANSMEMBRANE-HELICES-VII

      The Journal of biological chemistry
    42. HEGDE VR; DAI P; CHU M; PATEL M; BRYANT R; TERRACCIANO J; DAS PR; PUAR MS
      NEUROKININ RECEPTOR INHIBITORS - FERMENTATION, ISOLATION, PHYSICOCHEMICAL PROPERTIES, STRUCTURE AND BIOLOGICAL-ACTIVITY

      Journal of antibiotics
    43. LUNDSTROM K; HAWCOCK AB; VARGAS A; WARD P; THOMAS P; NAYLOR A
      EFFECT OF SINGLE-POINT MUTATIONS OF THE HUMAN TACHYKININ NK1 RECEPTORON ANTAGONIST AFFINITY

      European journal of pharmacology
    44. ABDI A; JOHNS EJ
      THE EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS ON KIDNEY-FUNCTION IN 2-KIDNEY, 2-CLIP GOLDBLATT HYPERTENSIVE RATS

      European journal of pharmacology
    45. WILSON CJ; HUSAIN SS; STIMSON ER; DANGOTT LJ; MILLER KW; MAGGIO JE
      P-(4-HYDROXYBENZOYL)PHENYLALANINE - A PHOTOREACTIVE AMINO-ACID ANALOGAMENABLE TO RADIOIODINATION FOR ELUCIDATION OF PEPTIDE-PROTEIN INTERACTION APPLICATION TO SUBSTANCE-P RECEPTOR

      Biochemistry
    46. INOUE H; NAGATA N; KOSHIHARA Y
      EFFECT OF THE TACHYKININ RECEPTOR ANTAGONISTS, SR-140333, PK-888, ANDSR-142801, ON CAPSAICIN-INDUCED MOUSE EAR EDEMA

      Inflammation research
    47. ELLING CE; SCHWARTZ TW
      CONNECTIVITY AND ORIENTATION OF THE 7 HELICAL BUNDLE IN THE TACHYKININ NK-1 RECEPTOR PROBED BY ZINC SITE ENGINEERING

      EMBO journal
    48. LEE WJ; KIM KS; YANG EK; LEE JH; LEE EJ; PARK JS; KIM HJ
      EFFECT OF BRAIN ANGIOTENSIN-II AT(1), AT(2), AND CHOLINERGIC RECEPTORANTAGONISM ON DRINKING IN WATER-DEPRIVED RATS

      Regulatory peptides
    49. LIENARD F; THORNTON SN; MARTIAL FP; MOUSSEAU MC; NICOLAIDIS S
      ANGIOTENSIN-II RECEPTOR SUBTYPE ANTAGONISTS CAN BOTH STIMULATE AND INHIBIT SALT APPETITE IN RATS

      Regulatory peptides
    50. SUMANCHAUHAN N; MEECHAM KG; WEBDALE L; HUNTER JC; PRITCHARD MC; WOODRUFF GN; HILL DR
      THE INFLUENCE OF GUANYL NUCLEOTIDE ON AGONIST AND ANTAGONIST AFFINITYAT GUINEA-PIG CCK-B GASTRIN RECEPTORS - BINDING-STUDIES USING [H-3] PD140376/

      Regulatory peptides
    51. HORWELL D; PRITCHARD M; RAPHY J; RATCLIFFE G
      TARGETED MOLECULAR DIVERSITY - DESIGN AND DEVELOPMENT OF NONPEPTIDE ANTAGONISTS FOR CHOLECYSTOKININ AND TACHYKININ RECEPTORS

      Immunopharmacology
    52. LI ZY; BOSCH SM; SMITH TL; DIZ DI
      INTERACTIONS OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS AT IMIDAZOLINE GUANIDINIUM RECEPTOR-SITES IN RAT FOREBRAIN/

      Journal of cardiovascular pharmacology
    53. MEYER G; BEINBORN M; SEWING KF
      CHARACTERIZATION OF CCKA RECEPTOR-MEDIATED PEPSINOGEN SECRETION IN PORCINE CHIEF CELLS

      Pharmacology
    54. HJORTH SA; THIRSTRUP K; SCHWARTZ TW
      RADIOLIGAND-DEPENDENT DISCREPANCY IN AGONIST AFFINITIES ENHANCED BY MUTATIONS IN THE KAPPA-OPIOID RECEPTOR

      Molecular pharmacology
    55. TIAN Y; WU LH; PU YM; HUANG CC; CHUNG FZ
      STRUCTURAL MOTIFS ENCODED BY INDIVIDUAL EXONS OF THE HUMAN NEUROKININ-1 RECEPTOR GENE INTERACT DIFFERENTIALLY WITH SELECTIVE AGONISTS AND ANTAGONISTS

      Journal of neurochemistry
    56. GIRAULT S; SAGAN S; BOLBACH G; LAVIELLE S; CHASSAING G
      THE USE OF PHOTOLABELED PEPTIDES TO LOCALIZE THE SUBSTANCE-P-BINDING SITE IN THE HUMAN NEUROKININ-1 TACHYKININ RECEPTOR

      European journal of biochemistry
    57. NIRULA V; ZHENG W; SOTHINATHAN R; SANDBERG K
      INTERACTION OF BIPHENYLIMIDAZOLE AND IMIDAZOLEACRYLIC ACID NONPEPTIDEANTAGONISTS WITH VALINE-108 IN TM-III OF THE AT(1) ANGIOTENSIN RECEPTOR

      British Journal of Pharmacology
    58. MOSIMANN R; IMBODEN H; FELIX D
      THE NEURONAL ROLE OF ANGIOTENSIN-II IN THIRST, SODIUM APPETITE, COGNITION AND MEMORY

      Biological Reviews of the Cambridge Philosophical Society
    59. RINDER J; LUNDBERG JM
      EFFECTS OF HCGRP-8-37 AND THE NK1-RECEPTOR ANTAGONIST SR-140.333 ON CAPSAICIN-EVOKED VASODILATION IN THE PIG NASAL-MUCOSA IN-VIVO

      Acta Physiologica Scandinavica
    60. LU XY; GROVE KL; ZHANG W; SPETH RC
      PHARMACOLOGICAL CHARACTERIZATION OF ANGIOTENSIN-II AT(2) RECEPTOR SUBTYPE HETEROGENEITY IN THE RAT ADRENAL-CORTEX AND MEDULLA

      Endocrine
    61. GULLY D; JEANJEAN F; PONCELET M; STEINBERG R; SOUBRIE P; LEFUR G; MAFFRAND JP
      NEUROPHARMACOLOGICAL PROFILE OF NONPEPTIDE NEUROTENSIN ANTAGONISTS

      Fundamental and clinical pharmacology
    62. JOSEPH MP; MAIGRET B; BONNAFOUS JC; MARIE J; SCHERAGA HA
      A COMPUTER MODELING POSTULATED MECHANISM FOR ANGIOTENSIN-II RECEPTOR ACTIVATION

      Journal of protein chemistry
    63. MAFFRAND JP; GULLY D; BOIGEGRAIN R; JEANJEAN F
      NEW POTENT AND SELECTIVE NONPEPTIDE ANTAGONISTS OF NEUROTENSIN RECEPTORS

      European journal of medicinal chemistry
    64. YOHANNAN MD; ERNSBERGER P
      HETEROGENEITY OF NEUROKININ, BINDING-SITES IN PORCINE RESPIRATORY-TRACT

      Peptides
    65. NAKA T; KUBO K; FURUKAWA Y
      NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGO NISTS

      Yuki Gosei Kagaku Kyokaishi
    66. CHUNG FZ; WU LH; TIAN Y; VARTANIAN MA; LEE H; BIKKER J; HUMBLET C; PRITCHARD MC; RAPHY J; SUMANCHAUHAN N; HORWELL DC; LALWANI ND; OXENDER DL
      2 CLASSES OF STRUCTURALLY DIFFERENT ANTAGONISTS DISPLAY SIMILAR SPECIES PREFERENCE FOR THE HUMAN TACHYKININ NEUROKININ(3) RECEPTOR

      Molecular pharmacology
    67. KIYAMA R; HONMA T; HAYASHI K; OGAWA M; HARA M; FUJIMOTO M; FUJISHITA T
      NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DESIGN, SYNTHESIS, AND IN-VITRO EVALUATION OF DIBENZO[A,D]CYCLOHEPTENE AND DIBENZO[B,F]OXEPIN DERIVATIVES - SEARCHING FOR BIOISOSTERES OF BIPHENYLYLTETRAZOLE USING A3-DIMENSIONAL SEARCH TECHNIQUE

      Journal of medicinal chemistry
    68. LIU JJ; PHILLIPS PA; BURRELL LM; BURTON BB; JOHNSTON CI
      HUMAN INTERNAL MAMMARY ARTERY RESPONSES TO NONPEPTIDE VASOPRESSIN ANTAGONISTS

      Clinical and experimental pharmacology and physiology
    69. SERVANT G; DUDLEY DT; ESCHER E; GUILLEMETTE G
      THE MARKED DISPARITY BETWEEN THE SIZES OF ANGIOTENSIN TYPE-2 RECEPTORS FROM DIFFERENT TISSUES IS RELATED TO DIFFERENT DEGREES OF N-GLYCOSYLATION

      Molecular pharmacology
    70. ITO H; SOGABE H; NAKARAI T; SATO Y; TOMOI M; KADOWAKI M; MATSUO M; TOKORO K; YOSHIDA K
      PHARMACOLOGICAL PROFILE OF FK480, A NOVEL CHOLECYSTOKININ TYPE-A RECEPTOR ANTAGONIST - COMPARISON TO LOXIGLUMIDE

      The Journal of pharmacology and experimental therapeutics
    71. BURNS L; CLARK KL; BRADLEY J; ROBERTSON MJ; CLARK AJL
      MOLECULAR-CLONING OF THE CANINE ANGIOTENSIN-II RECEPTOR - AN AT1-LIKERECEPTOR WITH REDUCED AFFINITY FOR DUP753

      FEBS letters
    72. GOSO C; POTIER E; MANZINI S; SZALLASI A
      COMPARISON OF TACHYKININ NK(1) RECEPTORS IN HUMAN IM9 AND U373-MG CELLS, USING ANTAGONIST (FK888, (PLUS-OR-MINUS)-CP-96,345, AND RP-67580) BINDING

      European journal of pharmacology
    73. DIETERICH KD; GRIGORIADIS DE; DESOUZA EB
      CORTICOTROPIN-RELEASING FACTOR RECEPTORS IN HUMAN SMALL-CELL LUNG-CARCINOMA CELLS - RADIOLIGAND BINDING, 2ND-MESSENGER, AND NORTHERN BLOT ANALYSIS DATA

      Endocrinology
    74. HOSOKI R; YANAGISAWA M; GUO JZ; YOSHIOKA K; MAEHARA T; OTSUKA M
      EFFECTS OF RP-67580, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON A PRIMARY AFFERENT-EVOKED RESPONSE OF VENTRAL ROOTS IN THE NEONATAL RAT SPINAL-CORD

      British Journal of Pharmacology
    75. SCHAMBYE HT; VONWIJK B; HJORTH SA; WIENEN W; ENTZEROTH M; BERGSMA DJ; SCHWARTZ TW
      MUTATIONS IN TRANSMEMBRANE SEGMENT-VII OF THE AT(1) RECEPTOR DIFFERENTIATE BETWEEN CLOSELY-RELATED INSURMOUNTABLE AND COMPETITIVE ANGIOTENSIN ANTAGONISTS

      British Journal of Pharmacology
    76. MALCANGIO M; BOWERY NG
      EFFECT OF THE TACHYKININ NK1 RECEPTOR ANTAGONISTS, RP-67580 AND SR-140333, ON ELECTRICALLY-EVOKED SUBSTANCE-P RELEASE FROM RAT SPINAL-CORD

      British Journal of Pharmacology
    77. MAGGI CA; PATACCHINI R; MEINI S; QUARTARA L; SISTO A; POTIER E; GIULIANI S; GIACHETTI A
      COMPARISON OF TACHYKININ NK1 AND NK2 RECEPTORS IN THE CIRCULAR MUSCLEOF THE GUINEA-PIG ILEUM AND PROXIMAL COLON

      British Journal of Pharmacology
    78. BALMFORTH AJ; BRYSON SE; AYLETT AJ; WARBURTON P; BALL SG; PUN KT; MIDDLEMISS D; DREW GM
      COMPARATIVE PHARMACOLOGY OF RECOMBINANT RAT AT(1A), AT(1B) AND HUMAN AT(1) RECEPTORS EXPRESSED BY TRANSFECTED COS-M6 CELLS

      British Journal of Pharmacology
    79. WANG ZY; TUNG SR; STRICHARTZ GR; HAKANSON R
      NONSPECIFIC ACTIONS OF THE NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS, CP-96,345, RP-67580 AND SR-48968, ON NEUROTRANSMISSION

      British Journal of Pharmacology
    80. ISHIZAKI H; OHTAWA M
      INHIBITORY EFFECT OF THE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS ACTIVE METABOLITE, E-3174, ON CAMP-PHOSPHODIESTERASE - ADDITIONAL ACTION OF THE ANTAGONISTS

      Biochemical pharmacology
    81. WEYER U; SCHAFER R; HIMMLER A; MAYER SK; BURGER E; CZERNILOFSKY AP; STRATOWA C
      ESTABLISHMENT OF A CELLULAR-ASSAY SYSTEM FOR G-PROTEIN-LINKED RECEPTORS - COUPLING OF HUMAN NK2 AND 5-HT(2) RECEPTORS TO PHOSPHOLIPASE-C ACTIVATES A LUCIFERASE REPORTER GENE

      Receptors & channels
    82. RENZETTI AR; BARSACCHI P; CATALIOTO RM; CRISCUOLI M; MIZRAHI J
      DIFFERENTIAL EFFECT OF DITHIOTHREITOL AND DUP-753 ON ANGIOTENSIN-II RECEPTOR SUBTYPES IN BOVINE CEREBELLAR CORTEX

      Peptides
    83. EBERHARDT RT; KEVAK RM; KANG PM; FRISHMAN WH
      ANGIOTENSIN-II RECEPTOR BLOCKADE - AN INNOVATIVE APPROACH TO CARDIOVASCULAR PHARMACOTHERAPY

      Journal of clinical pharmacology
    84. TIMMERMANS PBMWM; WONG PC; CHIU AT; HERBLIN WF; BENFIELD P; CARINI DJ; LEE RJ; WEXLER RR; SAYE JAM; SMITH RD
      ANGIOTENSIN-II RECEPTORS AND ANGIOTENSIN-II RECEPTOR ANTAGONISTS

      Pharmacological reviews
    85. SEABROOK GR; MAIN MJ; RAZZAQUE Z; LONGMORE J
      DIFFERENCES IN THE EFFECTS OF TACHYKININ NK(1) RECEPTOR ANTAGONISTS -NEURONAL VERSUS SMOOTH-MUSCLE TISSUES

      European journal of pharmacology
    86. MOUSSAOUI SM; MONTIER F; CARRUETTE A; BLANCHARD JC; LADURON PM; GARRET C
      A NONPEPTIDE NK1-RECEPTOR ANTAGONIST, RP-67580, INHIBITS NEUROGENIC INFLAMMATION POSTSYNAPTICALLY

      British Journal of Pharmacology
    87. CHATZIANTONIOU C; ARENDSHORST WJ
      ANGIOTENSIN RECEPTOR-SITES IN RENAL VASCULATURE OF RATS DEVELOPING GENETIC-HYPERTENSION

      The American journal of physiology
    88. KANG J; SUMNERS C; POSNER P
      ANGIOTENSIN-II TYPE-2 RECEPTOR-MODULATED CHANGES IN POTASSIUM CURRENTS IN CULTURED NEURONS

      The American journal of physiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 04:26:23